Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin vs Doxycycline Sclerotherapy for Pediatric Lymphatic Malformations
NCT07320001Phase 2Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of doxycycline in Lymphatic Malformation (LM) (2 arms). Primary endpoint: Change in lymphatic malformation volume at 6 months. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
Lymphatic Malformation (LM)
Beyond the preview
Go deeper on NCT07320001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07320001.